{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:47:51Z","timestamp":1787993271765,"version":"build-2784847793"},"reference-count":40,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,1]]},"DOI":"10.1210\/jc.2003-031672","type":"journal-article","created":{"date-parts":[[2004,10,7]],"date-time":"2004-10-07T21:53:20Z","timestamp":1097186000000},"page":"4879-4885","source":"Crossref","is-referenced-by-count":66,"title":["Prevention of Postmenopausal Bone Loss: Six-Year Results from the Early Postmenopausal Intervention Cohort Study"],"prefix":"10.1210","volume":"89","author":[{"given":"Michael R.","family":"McClung","sequence":"first","affiliation":[{"name":"Oregon Osteoporosis Center (M.R.M.), Portland, Oregon 97213;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Wasnich","sequence":"additional","affiliation":[{"name":"Radiant Research-Honolulu (R.D.W.), Honolulu, Hawaii 96814;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Hosking","sequence":"additional","affiliation":[{"name":"Nottingham City Hospital (D.J.H.), Nottingham, NG5 1PB, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Center for Clinical and Basic Research (C.C., P.R.), Ballerup DK-2750, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Ravn","sequence":"additional","affiliation":[{"name":"Center for Clinical and Basic Research (C.C., P.R.), Ballerup DK-2750, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wu","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories (M.W., A.M.M, J.Y., P.D.R., A.C.S), Rahway, New Jersey 07065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Mantz","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories (M.W., A.M.M, J.Y., P.D.R., A.C.S), Rahway, New Jersey 07065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yates","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories (M.W., A.M.M, J.Y., P.D.R., A.C.S), Rahway, New Jersey 07065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Ross","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories (M.W., A.M.M, J.Y., P.D.R., A.C.S), Rahway, New Jersey 07065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Arthur C.","family":"Santora","sequence":"additional","affiliation":[{"name":"Merck Research Laboratories (M.W., A.M.M, J.Y., P.D.R., A.C.S), Rahway, New Jersey 07065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Early Postmenopausal Intervention Cohort (EPIC) Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041120401982800_R1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJM199208273270908","article-title":"The prevention and treatment of osteoporosis.","volume":"327","author":"Riggs","year":"1992","journal-title":"N Engl J Med"},{"key":"2019041120401982800_R2"},{"key":"2019041120401982800_R3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-129-2-199807150-00002","article-title":"Physical activity and osteoporotic fracture risk in older women.","volume":"129","author":"Gregg","year":"1998","journal-title":"Ann Intern Med"},{"issue":"2A","key":"2019041120401982800_R4","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1016\/S0002-9343(97)90023-1","article-title":"The socioeconomic burden of fractures: today and in the 21st century","volume":"103","author":"Johnell","year":"1997","journal-title":"Am J Med"},{"key":"2019041120401982800_R5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women\u2019s Health Initiative randomized controlled trial.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"2019041120401982800_R6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0002-9343(01)00647-7","article-title":"Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen\/Progestin Replacement Study (HERS).","volume":"110","author":"Cauley","year":"2001","journal-title":"Am J Med"},{"key":"2019041120401982800_R7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","article-title":"Menopausal hormone replacement therapy and risk of ovarian cancer.","volume":"288","author":"Lacey","year":"2002","journal-title":"JAMA"},{"key":"2019041120401982800_R8","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women\u2019s Health Initiative Memory Study: a randomized controlled trial.","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"2019041120401982800_R9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial.","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"2019041120401982800_R10","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa030311","article-title":"Effects of estrogen plus progestin on health-related quality of life.","volume":"348","author":"Hays","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041120401982800_R11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041120401982800_R12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/8756-3282(95)00436-X","article-title":"Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.","volume":"18","author":"Devogelaer","year":"1996","journal-title":"Bone"},{"key":"2019041120401982800_R13","first-page":"3109","article-title":"Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women.","volume":"85","author":"Tonino","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041120401982800_R14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"2019041120401982800_R15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","article-title":"Prevention of nonvertebral fractures by alendronate. A meta-analysis.","volume":"277","author":"Karpf","year":"1997","journal-title":"JAMA"},{"key":"2019041120401982800_R16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-128-4-199802150-00001","article-title":"Alendronate prevents postmenopausal bone loss in women without osteoporosis.","volume":"128","author":"McClung","year":"1998","journal-title":"Ann Intern Med"},{"key":"2019041120401982800_R17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-131-12-199912210-00005","article-title":"Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized controlled trial.","volume":"131","author":"Ravn","year":"1999","journal-title":"Ann Intern Med"},{"key":"2019041120401982800_R18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199802193380801","article-title":"Prevention of bone loss with alendronate in postmenopausal women under 60 years of age.","volume":"338","author":"Hosking","year":"1998","journal-title":"N Engl J Med"},{"key":"2019041120401982800_R19"},{"key":"2019041120401982800_R20","first-page":"1693","article-title":"Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.","volume":"79","author":"Garnero","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041120401982800_R21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/8756-3282(95)00075-O","article-title":"Decreased bone turnover in oral contraceptive users.","volume":"16","author":"Garnero","year":"1995","journal-title":"Bone"},{"key":"2019041120401982800_R22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women.","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041120401982800_R23","first-page":"1492","article-title":"Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal.","volume":"85","author":"Ravn","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041120401982800_R24","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1517\/14656566.2.9.1461","article-title":"Update on alendronate for osteoporosis: once-weekly dosing.","volume":"2","author":"Schnitzer","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"2019041120401982800_R25","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1359\/jbmr.1999.14.9.1622","article-title":"Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women.","volume":"14","author":"Ravn","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2019041120401982800_R26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures.","volume":"12","author":"Melton III","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2019041120401982800_R27","first-page":"319","article-title":"Biochemical markers for the assessment of bone turnover","author":"Delmas","year":"1995","journal-title":"In: Riggs BL, Melton III LJ, eds. Osteoporosis: etiology, diagnosis, and management. 2nd ed. Philadelphia: Lippincott-Raven Publishers;"},{"key":"2019041120401982800_R28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI110882","article-title":"Increase in serum bone \u03b3-carboxyglutamic acid protein with aging in women: implications for the mechanism of age-related bone loss.","volume":"71","author":"Delmas","year":"1983","journal-title":"J Clin Invest"},{"key":"2019041120401982800_R29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(84)90360-X","article-title":"Differences in serum bone Gla-protein with age and sex.","volume":"1","author":"Epstein","year":"1984","journal-title":"Lancet"},{"key":"2019041120401982800_R30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jbmr.5650080516","article-title":"Immunoassay of pyridinoline cross-link excretion in normal adults and in Paget\u2019s disease.","volume":"8","author":"Delmas","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2019041120401982800_R31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041120401982800_R32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S8756-3282(00)00451-8","article-title":"Bone loss in relation to menopause: a prospective study during 16 years.","volume":"28","author":"Ahlborg","year":"2001","journal-title":"Bone"},{"key":"2019041120401982800_R33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s001980200001","article-title":"Changes in bone mineral density with age in men and women: a longitudinal study.","volume":"13","author":"Warming","year":"2002","journal-title":"Osteoporos Int"},{"key":"2019041120401982800_R34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S8756-3282(02)00678-6","article-title":"Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent.","volume":"30","author":"Bjarnasson","year":"2002","journal-title":"Bone"},{"key":"2019041120401982800_R35","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","article-title":"Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.","volume":"87","author":"Hochberg","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041120401982800_R36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/j.1552-4604.1997.tb04292.x","article-title":"Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy?","volume":"37","author":"Gibaldi","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"2019041120401982800_R37","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2105\/AJPH.80.10.1266","article-title":"Are women using postmenopausal estrogens? A community survey.","volume":"80","author":"Harris","year":"1990","journal-title":"Am J Public Health"},{"key":"2019041120401982800_R38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-0528.1992.tb13732.x","article-title":"Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis.","volume":"99","author":"Ryan","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl 3","key":"2019041120401982800_R39","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/BF01623005","article-title":"Design of the fracture intervention trial","volume":"Int","author":"Black","year":"1993","journal-title":"Osteoporos"},{"key":"2019041120401982800_R40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.","volume":"18","author":"Eastell","year":"2003","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/89\/10\/4879\/10771568\/jcem4879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T07:22:25Z","timestamp":1555053745000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/89\/10\/4879\/2844182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2003-031672","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,1]]}}}